TIMP1 and Hepatic fibrosis: This phenomenon could be a key element explaining the slowness of fibrosis reversion, especially since it has been shown that treatment based on anti-TIMP1 antibodies leads to an improvement in hepatic fibrosis induced by CCl4 in rodents [36].